PHOENIX, AZ / ACCESSWIRE / November 14, 2024 / A recent study from SleepScore Labs, which analyzed 878 nights of objectively measured sleep, has revealed promising results regarding the PuroAir 240 air purifier. The findings indicate that the PuroAir 240 not only enhances deep sleep for adults experiencing allergies but also significantly alleviates perceived allergy symptoms.
Conducted with participants who reported nighttime allergies, the study utilized the SleepScore Max, a sleep-tracking device developed by SleepScore Labs, to assess sleep quality objectively. Results showed that the PuroAir 240 was associated with a 6% increase in deep sleep duration, translating to an average of 4 more minutes of deep sleep per night. Additionally, users experienced an 8% reduction in nighttime awakenings, contributing to a more restful sleep experience.
Participants also reported substantial self-perceived improvements in their overall sleep quality including:
Users reported a 57% increase in sleep quality when using the PuroAir 240.
Users reported a 61% increase in feeling satisfied with their sleep on a weekly basis, increasing from an average of 2.5 to 4 days per week.
Users experienced a 41% decrease in nights per week they perceived tossing and turning during the night and a 52% increase in feeling well-rested each morning.
Moreover, the study highlighted noteworthy reductions in allergy symptoms among participants. On average, users reported a 27% reduction in the perceived severity of their nighttime allergy symptoms, including:
36% decrease in sneezing.
55% decrease in runny or stuffy nose.
63% decrease in itchy nose or eyes.
64% decrease in red or watery eyes.
The PuroAir 240 achieved these positive outcomes without the need for invasive or pharmacological interventions, offering a comfortable, cost-effective solution to those suffering from allergies and sleep disturbances.
User feedback from the study was overwhelmingly positive, with 80% of participants indicating they felt that the air purifier helped reduce their allergy symptoms and improved their sleep quality. An impressive 100%expressed enjoyment in using the device, and 97% stated they would recommend it to friends, family, or coworkers.
"We are excited to see evidence supporting the effectiveness of the PuroAir 240 in improving both sleep quality and allergy symptoms," said Holly Rus, PhD, Head of Scientific Research at SleepScore Labs. "Data from our studies, like the one on the PuroAir 240, provide critical insights that enable sleep product companies to enhance their offerings and customers to feel confident in the products they buy."
"Our mission at PuroAir has always been to create solutions that improve lives, and the results from this study are a testament to that goal," said Robby Choueiri, Co-Founder and CEO of PuroAir. "The PuroAir 240 was designed with the user in mind, and seeing these real-world improvements in both sleep quality and allergy symptoms reaffirms the impact our technology can have. We're thrilled that the PuroAir 240 is helping people wake up feeling more refreshed and breathe easier at night, without the need for invasive treatments."
The full study, including a summary, methodology, key findings, and detailed results can be found at:
https://getpuroair.com/blogs/news/sleepscore-labs-puroair-report
The PuroAir 240 is available for purchase at:
https://getpuroair.com/products/puroair-240-air-purifier
About PuroAir
PuroAir is a leader in delivering superior air purification products. As one of the most trusted names in air purification and healthy indoor air quality, PuroAir is committed to innovation and advancements in air purification technology. PuroAir is dedicated to promoting environmentally sustainable business practices and supporting communities through health-focused philanthropy.
Follow PuroAir
PuroAir on Instagram
PuroAir on Facebook
PuroAir on YouTube
PuroAir Media Contacts:
Kelly D'Elena, Marketing
866-552-9322
kelly@getpuroair.com
Brian McDermott, Public Relations
215-205-3787
brian@brianpr.co
SOURCE: PuroAir
View the original press release on accesswire.com
